Admission Date:  [**2196-3-16**]              Discharge Date:   [**2196-4-20**]

Date of Birth:  [**2131-7-13**]             Sex:   M

Service: MEDICINE

Allergies:
Lisinopril / Cefepime / Aztreonam

Attending:[**Last Name (NamePattern1) 4377**]
Chief Complaint:
Fatigue.

Major Surgical or Invasive Procedure:
1. Bronchoscopy
2. TFN nailing


History of Present Illness:
This is a 64yom with hx of relapsed AML s/p double-cord
transplant, now C3D24 of dacogen presenting with fatigue x 3
days. Patient was recently admitted from [**3-4**] to [**3-10**] for fever,
neutropenia and sore throat. Patient was treated empirically
with meropenem for pharyngitis and was switched to PO
Moxifloxacin . He was to complete his course on [**2196-3-17**]. He
reports however that he stopped taking the antibiotic because he
was feeling well. He felt well on Saturday and Sunday however
Monday morning described feeling "tired." He denied any fevers,
chills, malaise, rash, URI symptoms, sinus pressure, chest pain,
abdominal symptoms, or urinary symptoms. He did endorese however
decreased PO intake and dark urine. He remained tired on Tuesday
and yesterday. He reported dyspnea on exertion yesterday without
cough, chest pain, palpitations, or lower extremity edema. He
presented to clinic today and was directly admitted for further
work-up.
.
Of note patient was seen in clinic also on [**3-14**] during which
time, he also reported fatigue. His creatinine was checked and
was 1.2. Diovan was held for this elevated creatinine.
.
On the floor, patient appeared fatigue but was otherwise not in
any distress. Other than feeling tired, he had no complaints.

Past Medical History:
ONCOLOGIC HISTORY:
[**2195-3-27**]: Sent to [**Hospital6 33**] by PCP for
pancytopenia - WBC: 0.7, Hb: 7, HCT:19.8, PLT: 8.
[**2195-3-31**]: Bone marrow biopsy that showed 50% blasts.
Transferred to [**Hospital1 18**] for treatment of acute leukemia
[**2195-4-2**]: 7+3 chemo
[**2195-4-4**]: Febrile neutropenia. Developed significant rash
from drug allergy
[**2195-4-15**]: Day 14 7+3 bone marrow demonstrated
hypocellularity, but persistence of AML
[**2195-4-21**]: fungal pneumonia, had bronchoscopy on [**2195-4-24**]
[**2195-4-22**]: Repeat marrow again showed persistent disease
[**2195-5-2**]: Discharged from [**Hospital1 18**]
[**2195-5-11**]: C1D1 Dacogen
[**2195-6-8**]: C2D1 Dacogen
[**2195-8-3**]: Admission for double cord transplant, Day 0
[**2195-8-10**]: Course complicated by neutropenic fever,
respiratory distress/heart failure requiring
intubation, and acute kidney injury.
[**2195-9-18**]: Discharged after above complicated post-tx course
.
Other PMHx:
- NSTEMI in post-transplant period.
- [**Last Name (un) **] in post-transplant course, improving, current Cr 1.4.
- History of C.Diff in post-transplant course, on Vanco taper.
Repeated C.diff negative.
- Hypertension: borderline. Per pt, he did not take any
medication before BMT.
- Dyslipidemia: not on medication.
- Non-insulin dependent diabetes.
- Tubular adenoma in 2/[**2190**].
- BPH, not on medication.
- Shoulder and back surgery following MVA in [**2187**]

Social History:
- Divorced, lives with son, who is a freshman in college.
- Former smoker - 1.5 packs of cigarettes/daily, quit prior to
transplant.
- Drinks 1-2 drinks / week with no heavy drinking in the past.
- No recreational drug use.


Family History:
- Diabetes and breast cancer in mother.
- Brother died at age 23 of brain tumor.
- Has 3 sisters all in good health.
- Daughter age 31 and son is a college freshman.

Physical Exam:
Admission Physical Exam:
VS: T  98.1 BP 104.72 HR 85 RR 18 SpO2 100% RA
GEN: AOx3, NAD, flat affect
HEENT: PERRLA. dry MM. no LAD. No pharyngeal erythema. Neck
supple. No cervical, supraclavicular LAD. No tenderness to
palapation over the neck
Cards: RR S1/S2 normal. no murmurs/gallops/rubs.
Pulm: CTAB no crackles or wheezes, no stridor
Abd: BS+, soft, NT, no rebound/guarding, no HSM, no [**Doctor Last Name 515**]
sign
Extremities: wwp, no edema. DPs, PTs 2+.
Skin: no rashes or bruising
Neuro: CNs II-XII intact. 5/5 strength in U/L extremities. DTRs
2+ BL. sensation intact to LT, cerebellar fxn intact (FTN). gait
deferred.

Exam upon discharge: Expired.


Pertinent Results:
Admission Labs:
[**2196-3-16**] 08:05AM BLOOD WBC-1.5* RBC-2.69* Hgb-8.8* Hct-23.8*
MCV-89 MCH-32.7* MCHC-36.9* RDW-13.5 Plt Ct-27*
[**2196-3-16**] 08:05AM BLOOD Neuts-49* Bands-0 Lymphs-48* Monos-1*
Eos-0 Baso-1 Atyps-0 Metas-0 Myelos-0 Blasts-1*
[**2196-3-16**] 08:05AM BLOOD Hypochr-NORMAL Anisocy-NORMAL Poiklo-2+
Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL Spheroc-1+
Ovalocy-1+ Tear Dr[**Last Name (STitle) **]1+
[**2196-3-17**] 07:00AM BLOOD PT-15.9* PTT-30.4 INR(PT)-1.4*
[**2196-3-17**] 07:00AM BLOOD Gran Ct-403*
[**2196-3-16**] 10:20AM BLOOD UreaN-13 Creat-1.3* Na-136 K-3.4 Cl-101
HCO3-30 AnGap-8
[**2196-3-16**] 10:20AM BLOOD Albumin-3.9 Calcium-8.4 Phos-2.8 Mg-1.6
[**2196-3-18**] 06:10AM BLOOD Vanco-17.2

Labs prior to discharge:
There were no labs drawn from [**Date range (3) 86410**].

Micro:
[**2196-4-11**] BLOOD CULTURE Blood Culture, Routine-PENDING

[**2196-4-11**] BLOOD CULTURE Blood Culture, Routine-PENDING

[**2196-4-8**] BLOOD CULTURE Blood Culture, Routine-PENDING

[**2196-4-8**] BLOOD CULTURE Blood Culture, Routine-PENDING

[**2196-4-8**] BLOOD CULTURE Blood Culture, Routine-PENDING

[**2196-4-7**] STOOL CLOSTRIDIUM DIFFICILE TOXIN A & B
TEST-FINAL
[**2196-4-7**] BLOOD CULTURE Blood Culture, Routine-FINAL
[**2196-4-6**] CSF;SPINAL FLUID GRAM STAIN-FINAL; FLUID
CULTURE-FINAL; FUNGAL CULTURE-PRELIMINARY; ACID FAST
CULTURE-PRELIMINARY; VIRAL CULTURE-PRELIMINARY
[**2196-4-6**] URINE URINE CULTURE-FINAL
[**2196-4-5**] BLOOD CULTURE Blood Culture, Routine-FINAL
[**2196-4-5**] SEROLOGY/BLOOD RAPID PLASMA REAGIN
TEST-FINAL
[**2196-4-5**] SEROLOGY/BLOOD CRYPTOCOCCAL ANTIGEN-FINAL
[**2196-4-5**] BLOOD CULTURE Blood Culture, Routine-FINAL
[**2196-3-30**] Immunology (CMV) CMV Viral Load-FINAL
[**2196-3-28**] MRSA SCREEN MRSA SCREEN-FINAL
[**2196-3-28**] URINE URINE CULTURE-FINAL
[**2196-3-27**] BLOOD CULTURE Blood Culture, Routine-FINAL
[**2196-3-25**] URINE URINE CULTURE-FINAL
[**2196-3-24**] BLOOD CULTURE Blood Culture, Routine-FINAL
[**2196-3-23**] BLOOD CULTURE Blood Culture, Routine-FINAL
[**2196-3-23**] Rapid Respiratory Viral Screen & Culture
Respiratory Viral Culture-FINAL; Respiratory Viral Antigen
Screen-FINAL
[**2196-3-23**] BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL;
RESPIRATORY CULTURE-FINAL {YEAST}; LEGIONELLA CULTURE-FINAL;
Immunoflourescent test for Pneumocystis jirovecii
(carinii)-FINAL {POSITIVE FOR PNEUMOCYSTIS JIROVECII (CARINII)};
FUNGAL CULTURE-FINAL {YEAST}; ACID FAST SMEAR-FINAL; ACID FAST
CULTURE-PRELIMINARY; VIRAL CULTURE: R/O
CYTOMEGALOVIRUS-PRELIMINARY
[**2196-3-22**] URINE URINE CULTURE-FINAL
[**2196-3-21**] Rapid Respiratory Viral Screen & Culture
Respiratory Viral Antigen Screen-FINAL; Respiratory Viral
Culture-FINAL
[**2196-3-21**] BLOOD CULTURE Blood Culture, Routine-FINAL
[**2196-3-21**] BLOOD CULTURE Blood Culture, Routine-FINAL
[**2196-3-21**] Rapid Respiratory Viral Screen & Culture
Respiratory Viral Culture-FINAL; Respiratory Viral Antigen
Screen-FINAL
[**2196-3-21**] Immunology (CMV) CMV Viral Load-FINAL
[**2196-3-21**] URINE URINE CULTURE-FINAL
[**2196-3-20**] SPUTUM GRAM STAIN-FINAL; RESPIRATORY
CULTURE-FINAL {YEAST}; FUNGAL CULTURE-FINAL {YEAST};
Immunoflourescent test for Pneumocystis jirovecii
(carinii)-FINAL
[**2196-3-20**] BLOOD CULTURE Blood Culture, Routine-FINAL
[**2196-3-20**] BLOOD CULTURE Blood Culture, Routine-FINAL
[**2196-3-19**] SPUTUM GRAM STAIN-FINAL; RESPIRATORY
CULTURE-FINAL; Immunoflourescent test for Pneumocystis jirovecii
(carinii)-FINAL; FUNGAL CULTURE-FINAL
[**2196-3-19**] SEROLOGY/BLOOD CRYPTOCOCCAL ANTIGEN-FINAL
[**2196-3-19**] BLOOD CULTURE Blood Culture, Routine-FINAL
[**2196-3-19**] BLOOD CULTURE Blood Culture, Routine-FINAL
[**2196-3-18**] BLOOD CULTURE Blood Culture, Routine-FINAL
[**2196-3-18**] BLOOD CULTURE Blood Culture, Routine-FINAL
[**2196-3-17**] BLOOD CULTURE Blood Culture, Routine-FINAL
[**2196-3-17**] BLOOD CULTURE Blood Culture, Routine-FINAL
[**2196-3-16**] URINE Legionella Urinary Antigen 